Pfizer Inc.'s Zithromax antibiotic may quadruple the risk of being re-infected with a potentially blinding eye infection that the drug is intended to treat.
Zithromax worked against the initial outbreak of the infection, called trachoma, those taking the drug were more likely to be re-infected than those treated with surgery alone, said a study published yesterday in the Journal of the American Medical Association.
The antibiotic appeared to blunt the immune system's ability to develop natural resistance by shortening exposure to the bacteria, the study said. „This is like the law of unintended consequences,” said Deborah Dean, co-author of the paper and a researcher at Children's Hospital Oakland Research Institute who is working on a vaccine for Trachoma.
Trachoma is the second-most frequent cause of blindness. The study should encourage efforts to find a vaccine for trachoma since antibiotics don't appear to treat the long-term problem. About 80 million people, most in developing countries, are infected, and 8 million have been blinded or lost some vision, according to the International Trachoma Initiative.
However, Pfizer infectious disease researcher Charles Knirsch said he is skeptical of the paper's conclusion related to natural immunity because the researchers didn't provide evidence to support that finding. He said there is no good way to test to determine whether someone has developed immunity to trachoma. The higher recurrence of infections among a certain group might be explained by geographical location. Other studies, including one on patients in Morocco, showed that treating the entire population with Zithromax almost wipes out the disease, Knirsch said.
Link
Filed under Eye Treatment | Tags: eye, Lost | 1 Comment
Related?
Contagious Eye Infection Going Around Bostonia CommunityOctober 26th, 2006 Local doctors say a contagious eye infection is on the rise and so are bacterial infections that don't respond to traditional antibiotics. Doctor Matthew Guest at Neighborhood Healthcare in the Bostonia neighborhood of El Cajon says two illnesses are making their way through the area.
Artificial lens coated with antibiotic may reduce post operative eye infectionSeptember 9th, 2008 Now there is a good news for cataract patients as new research presented at the British Pharmaceutical Conference (BPC) in Manchester reveals that artificial lens if coated with an antibiotic named hydrogel, shows significant reduction in the risk of post-operative eye infection "endophthalmitis ". Infectious Endophthalmitis is a rare but serious inflammation of the tissues inside the eye that can lead to blindness.
Single Mass Antibiotic Treatment Is Not Enough To Treat And Eliminate TrachomaMarch 8th, 2006 A single mass antibiotic distribution is not an effective way to treat and eliminate trachoma -- an eye infection that can cause blindness -- in Ethiopian communities with high rates of the disease. That's the conclusion of a study in the March 8 issue of the Journal of the American Medical Association.
Antibiotic Fights Lymphoma of Eye Linked to ChlamydiaOctober 4th, 2006 The antibiotic doxycycline is proving an effective treatment for a lymphoma of the eye linked to chlamydia infection, Italian researchers report. This cancer of the eyelids and related tissues is called "ocular adnexal lymphoma of the MALT-type" (OAL).
Eye MRSA (Staph) Infection Becomes More Common; Can Lead To Total Vision Loss June 21st, 2008 John Breaux was a 52-year-old janitorial supplies salesman, who lost his eye sight within few days, after he acquired an infection in the eyelid of his right eye. Reason is MRSA, an especially aggressive and hard-to-treat form of staph infection.
Tips To Prevent Eye Infection May 15th, 2008 As tips to avoid eye infections, the doctors in Baharin, strongly suggested to avoid use of public swimming pools as they are a very common source to spread eye infections like eye flu or conjunctivitis. Also, they advise not to share the same face towels or flannels with the patients of the infected diseases.
Israel's Biotech Firm Sells Eye Treatment to PfizerOctober 4th, 2006 World biggest drug maker buys genetic eye treatment for blindness from Israeli biotech firm
Pfizer Inc., the world's biggest drug maker, said on Wednesday (09.28.06) it had acquired a genetic eye treatment from Israeli biotech company Quark Biotech Inc. (QBI) in a multi-million dollar deal.
Antibiotic Doxycycline Successfully Treats Eye LymphomaNovember 6th, 2006 A new study finds that the antibiotic doxycycline can treat a certain type of lymphoma that starts in the eye. The discovery could simplify treatment for patients and help researchers understand what causes this cancer.
May 10th, 2008 at 5:35 am
Please send me abstracts concerning efficiency, prophylaxis,therapy, and costs in comparison with tetracyclin in eye diseases